Abstract
The document deals with some ethical issues raised by the treatment of demented people. In particular the conceptual and empirical aspects of the assessment of awareness and competence of these patients are analysed, as well as the dilemmas related to the treatment of behavioral disorders.
Similar content being viewed by others
Bibliografia
Aalten P, Van Valen E, Clare L et al (2005) Awareness in dementia: in the eye of the beholder. Aging Mental Health 9:414–422
Barrett AM, Eslinger PJ, Ballentine NH, Heilman KM (2005) Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects. Neurology 64:693–699
Lope OL, Becker JT, Somsak D et al (1994) Awareness of cognitive deficits and anosognosia in probable Alzheimer’s disease. Eur Neurol 34:277–282.
Dalla Barba G, Parlato V, Lavarone A, Boller F (1995) Anosognosia, intrusions and ‘frontal’ functions in Alzheimer’s disease and depression. Neuropsychologia 33:247–259
Starkstein SE, Sabe L, Chemerinski E et al (1996) Two domains of anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 61:485–490
Starkstein SE, Mizrahi R (2006) Depression in Alzheimer’s disease. Exp Rev Neurother 6:887–895
Migliorelli R, Teson A, Sabe L et al (1995) Anosognosia in Alzheimer’s disease: a study of associated factors. J Neuropsychiatry Clin Neurosci 7:338–344
Markova IS, Berrios GE (1995) Insight in clinical psychiatry revisited. Compr Psychiatry 36:367–376
Ott BR, Fogel BS (1992) Measurement of depression in dementia: self vs clinician rating. Int J Geriatr Psychiatry 7:899–904
Fritsh T, McClendon MJ, Smyth KA, Ogrocki PK (2002) Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimertype dementia. Int Psychogeriatr 14:347–363
McDaniel KD, Edland SD, Heyman A (1995) Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer’s Disease. Alzheimer Dis Assoc Disord 9:101–104
Zanetti O, Vallotti B, Frisoni GB et al (1999) Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. J Gerontol Psychol Sci 54:100–106
Harwood DG, Sultzer DL, Wheatley MV (2000) Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol 13:82–88
Derouesné C, Thibault S, Lagha-Pierucci S et al (1999) Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry 14:1019–1030
Ott BR, Laflèche G, Whelihan WM et al (1996) Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord 10:68–76
Mega MS, Lee L, Dinov I et al (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:167–171
Petersen RC, Smith GE, Waring SC et al (1997) Aging, memory, and mild cognitive impairment. Int Psychogeriatr 9:65–69
Kalbe E, Salmon E, Perani D et al (2005) Anosognosia in very mild Alzheimer’s disease but not in mild cognitive impairment. Dement Geriatr Cogn Disord 19:349–356
Vogel A, Stokholm J, Gade A et al (2004) Awareness of deficits in mild cognitive impairment and Alzheimer’s disease: Do MCI patients have impaired insight? Dement Geriatr Cogn Disord 17:181–187
Mental Capacity Act (2005) www.opsi.gov.uk/-acts/acts2005/20050009.htm
Wong JG, Clare CH, Gunn Ng, Holland AJ (1999) Capacity to make health care decisions: its importance in clinical practice. Psychol Med 29:437–446
Beauchamp TL, Childress JF (2001) Principles of biomedical ethics, 5th edn. Oxford University Press, New York
Appelbaum PS, Grisso T (1988) Assessing patients’ capacities to consent to treatment. N Engl J Med 319:163–168
Karlawish JH, Casarett DJ, James BD et al (2005) The ability of persons with Alzheimer disease to make a decision about taking a AD treatment. Neurol 64:1514–1519
Marson D, Cody HA, Ingram KK, Harrell LE (1995) Neuropsychological predictors of competency in Alzheimer’s disease using a rational reasons legal standard. Arch Neurol 52:955–959
Marson D, Chatterjee A, Ingram KK, Harrell LE (1996) Toward a neurologic model of competency: cognitive predictors of capacity to consent in Alzheimer’s disease using three different legal standards. Neurology 46:666–672
Cairns R, Maddock C, Buchanan A et al (2005). Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psych 187:379–385
Pucci E, Belardinelli N, Borsetti G et al (2001) Information and competency for consent to pharmacological trials in Alzheimer disease: an empirical analysis in patients and family caregivers. Alzheimer Dis Assoc Disord 15:146–154
Stewart R (2006) Mental health legislation and decision making capacity. Autonomy in Alzheimer’s disease is ignored and neglected. BMJ 332:118–119
Etchells E, Darzins P, Silberfeld M et al (1999) Assessment of patient capacity to consent to treatment. J Gen Intern Med 14:27–34
Marson DC, Earnst KS, Jamil F et al (2000) Consistency of physicians’ legal standard and personal judgments of competency in patients with Alzheimer’s disease. J Am Geriatr Soc 48:911–918
Vellinga A, Smit JH, van Leeuwen E et al (2005) Decision-making capacity of elderly patients assessed through the vignette method: Imagination or reality? Aging and Mental Health 9:40–48
Grisso T, Appelbaum PS, Hill-Fotouhi C (1997) The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv 48:1415–1419
Brock D, Buchanan A (1989) Deciding for others: the ethics of surrogate decision-making. Cambridge University Press, Cambridge
Ditto PH, Danks JH, Smucker WD et al (2001) Advance directives as acts of communication. Arch Intern Med 161:421–430
Emanuel EJ, Emanuel LL (1992) Proxy decision making for incompetent patients. JAMA 267:2067–2071
Hereinafter “Oviedo Convention”: http://conventions.coe.int/-Treaty/ita/Treaties/Html/164.htm
Defanti CA (2004) In Voltz R, Bernat JL, Borasio GD et al (eds) Palliative care in neurology. Oxford University Press, New York
Caltagirone C, Bianchetti A, Trabucchi M et al; Italian Association of Psychogeriatrics (2005) Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. Drug Aging 22[Suppl 1]:26
— (2006) Recommendations on how to improve the legal rights and protection of adults with incapacity due to dementia. http://www.alzheimer-europe.org/?lm2=6A55EAF2CD2F#
Post SG (2000) The moral challenge of Alzheimer disease, 2nd edn. The Johns Hopkins University Press, Baltimore, MD
Jones M (2005) GentleCare. Carocci Faber Ed, Roma
Valla P (ed) (2002) Alzheimer. Architetture e Giardini come Strumento Terapeutico. Angelo Guerini Ed, Milan
Cannara A, Brizioli C, Brizioli E (2004) Progettare l’ambiente per l’Alzheimer. Specifiche progettuali per l’ambiente terapeutico. FrancoAngeli Ed, Milan
Lee PE, Gill SS, Freedman M et al (2004) Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: a systematic review. BMJ 329:75–79
Tannsjö T (2004) The Convention on Human rights and Biomedicine and the Use of Coercion in Psychiatry. Journal of Med Ethics 30:430–434
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Defanti, C.A., Tiezzi, A., Gasparini, M. et al. Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disorders. Neurol Sci 28, 216–231 (2007). https://doi.org/10.1007/s10072-006-0825-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-006-0825-x